Seminars in Colon & Rectal Surgery
Volume 18, Issue 4 , Pages 233-241 , December 2007

Plasma Protein Alterations Associated with Surgery

  • Daniel L. Feingold, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to: Daniel L. Feingold, MD, Columbia-Presbyterian Medical Center, Surgical Specialties, 161 Fort Washington Avenue, Suite 820, New York, NY 10032.

References 

  1. Schauer PR, Sirinek KR. The laparoscopic approach reduces the endocrine response to elective cholecystectomy. Am Surg. 1995;61:106–111
  2. Naito Y, Tamai S, Shingu K, et al. Responses of plasma adrenocorticotropic hormone, cortisol, and cytokines during and after upper abdominal surgery. Anesthesiology. 1992;77:426–431
  3. Jakeways MS, Mitchell V, Hashim IA, et al. Metabolic and inflammatory responses after open or laparoscopic cholecystectomy. Br J Surg. 1994;81:127–131
  4. Karayiannakis AJ, Makri GG, Mantzioka A, et al. Systemic stress response after laparoscopic or open cholecystectomy: a randomized trial. Br J Surg. 1997;84:467–471
  5. Glaser F, Sannwald GA, Buhr HJ, et al. General stress response to conventional and laparoscopic cholecystectomy. Ann Surg. 1995;221:372–380
  6. Chekhan EG, Pappas TN. Minimally invasive surgery. In: Sabiston’s Textbook of Surgery. (ed 16). Philadelphia, PA: W.B. Saunders Company; 2001;p. 292–310
  7. Shiromizu A, Suematsu T, Yamaguchi K, et al. Effects of laparotomy and laparoscopy on the establishment of lung metastasis in a murine model. Surgery. 2000;128:799–805
  8. Carter JJ, Feingold DL, Kirman I, et al. Laparoscopic-assisted cecectomy is associated with decreased formation of postoperative pulmonary metastases compared with open cecectomy in a murine model. Surgery. 2003;134:432–436
  9. Lee SW, Southall BA, Allendorf JD, et al. Tumor proliferative index is higher in mice undergoing laparotomy versus CO2 pneumoperitoneum. Dis Colon Rectum. 1999;42:477–481
  10. Allendorf JD, Bessler M, Whelan RL, et al. Better preservation of immune function after laparoscopic-assisted versus open bowel resection in a murine model. Dis Colon Rectum. 1996;39:S67–S72
  11. Allendorf JD, Marvin M, Bessler M, et al. Differences in tumor growth after open versus laparoscopic surgery are lost in an athymic model and are associated with differences in tumor proliferative index. Surg Forum. 1996;47:150–152
  12. Lee SW, Gleason NR, Southall JC, et al. A serum-soluble factor(s) stimulates tumor growth following laparotomy in a murine model. Surg Endosc. 2000;14:490–494
  13. Lee SW, Gleason NR, Stapleton GS, et al. Increased platelet-derived growth factor (PDGF) release after laparotomy stimulates tumor growth in mice. Surg Endosc. 2001;15:981–985
  14. Kirman I, Cekic V, Poltaratskaia N, et al. Plasma from patients undergoing major open surgery stimulates in vitro tumor growth: lower insulin-like growth factor binding protein 3 levels may, in part, account for this change. Surgery. 2002;132:186–192
  15. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression: review. J Natl Cancer Inst. 2000;92:1472–1489
  16. Kirman I, Cekic V, Poltaratskaia N, et al. Open surgery induces a dramatic decrease in circulating intact IGF-BP3 in patients with colorectal cancer not seen with laparoscopic surgery. Surg Endosc. 2005;19:55–59
  17. Rajah R, Valentinis B, Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem. 1997;272:12181–12188
  18. Fanayan S, Firth SM, Butt AJ, et al. Growth inhibition by insulin-like growth factor binding protein-3 in T47D breast cancer cells requires transforming growth factor (TGF)-β and the type II TGF-β receptor. J Biol Chem. 2000;275:39146–39151
  19. Williams AC, Smartt H, H-Zadeh AM, et al. Insulin-like growth factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced apoptosis of human colorectal carcinoma cells through inhibition of NF-χB. Cell Death Differ. 2007;14:137–145
  20. Lee HY, Chun KH, Liu B, et al. Insulin-like growth factor-binding protein-3 inhibits the growth of non-small cell lung cancer. Cancer Res. 2002;62:3530–3537
  21. Cotterill AM, Mendel P, Holly JMP, et al. The differential regulation of the circulating levels of insulin-like growth factors and their binding proteins (IGFBP) 1, 2, and 3 after elective abdominal surgery. Clin Endocrinol. 1996;44:91–101
  22. Kirman I, Poltaratskaia N, Cekic V, et al. Depletion of circulating Insulin-like growth factor binding protein 3 after open surgery is associated with high Interleukin-6 levels. Dis Colon Rectum. 2004;47:911–918
  23. Devi GR, Sprenger CC, Plymate SR, et al. Insulin-like growth factor binding protein-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivo. Prostate. 2002;51:141–152
  24. Kirman I, Poltoratskaia N, Sylla P, et al. Insulin-like growth factor-binding protein 3 inhibits growth of experimental colocarcinoma. Surgery. 2004;136:205–209
  25. Belizon A, Balik E, Kirman I, et al. Insulin-like growth factor binding protein-3 inhibits colitis-induced carcinogenesis. Dis Colon Rectum. 2007;50:1377–1383
  26. Fink MP. The role of cytokines as mediators of the inflammatory response. In: Sabiston’s Textbook of Surgery. (ed 16). Philadelphia, PA: W.B. Saunders Company; 2001;p. 28–43
  27. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. New Engl J Med. 1999;340:448–454
  28. Shenkin A, Fraser WD, Series J, et al. The serum IL-6 response to elective surgery. Lymphokine Res. 1989;8:123–127
  29. Ertel W, Faist E, Nestle C, et al. Kinetics of IL-2 and IL-6 synthesis following major mechanical trauma. J Surg Res. 1990;48:622–628
  30. Guo W, Dickerson C, Chrest FJ, et al. Increased levels of circulating IL-6 in burn patients. Clin Immunol Immunopathol. 1990;54:361–371
  31. Calandra T, Gerain J, Heumann D, et al. High circulating levels of IL-6 in patients with septic shock. Am J Med. 1991;91:23–29
  32. Schietroma M, Carlei F, Cappelli S, et al. Effects of cholecystectomy (laparoscopic versus open) on PMN elastase. Hepatogastroenterology. 2007;54:342–345
  33. Bellón JM, Manzano L, Bernardos L, et al. Cytokine levels after open and laparoscopic cholecystectomy. Eur Surg Res. 1997;29:27–34
  34. Bruce DM, Smith M, Walker CB, et al. Minimal access surgery for cholelithiasis induces an attenuated acute phase response. Am J Surg. 1999;178:232–234
  35. Delgado S, Lacy AM, Filella X, et al. Acute phase response in laparoscopic and open colectomy in colon cancer. Dis Colon Rectum. 2001;44:638–646
  36. Leung KL, Lai PB, Ho RL, et al. Systemic cytokine response after laparoscopic-assisted resection of rectosigmoid carcinoma. Ann Surg. 2000;231:506–511
  37. Schwenk W, Jacobi C, Mansmann U, et al. Inflammatory response after laparoscopic and conventional colorectal resections. Langenbeck’s Arch Surg. 2000;385:2–9
  38. Jacobi C, Wenger F, Müller JM. Immunologic changes during minimally invasive surgery. Dig Surg. 2002;19:459–463
  39. De Benedetti F, Meazza C, Oliveri M, et al. Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis. Endocrinology. 2001;142:4818–4826
  40. Sylla P, Nihalani A, Whelan RL. Microarray analysis of the differential effects of open and laparoscopic surgery on murine splenic T-cells. Surgery. 2006;139:92–103
  41. Belizon A, Kirman I, Balik E, et al. Major surgical trauma induces proteolysis of insulin-like growth factor binding protein-3 in transgenic mice and is associated with a rapid increase in circulating levels of matrix metalloproteinase-9. Surg Endosc. 2007;21:653–658
  42. Belizon A, Kirman I, Karten M, et al. Rapid increase in serum levels of matrix metalloproteinase-9 (MMP-9) postoperatively is associated with a decrease in the amount of intracellular MMP-9. Surg Innov. 2005;12:333–337
  43. Kirman I, Jain S, Cekic V, et al. Altered plasma matrix metalloproteinase-9/tissue metalloproteinase-1 concentration during the early post-operative period in patients with colorectal cancer. Surg Endosc. 2006;20:482–486
  44. Porter JF, Shen S, Denhardt DT. Tissue inhibitor of metalloproteinase-1 stimulates proliferation of human cancer cells by inhibiting a metalloproteinase. Br J Cancer. 2004;90:463–470
  45. Hewitt RE, Leach IH, Powe DG, et al. Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumors. Int J Cancer. 1991;49:666–672
  46. Zeng ZS, Guillem JG. Distinct pattern of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 messenger-RNA expression in human colorectal cancer and liver metastases. Br J Cancer. 1995;72:575–582
  47. Waas ET, Hendriks T, Lomme RMLM, et al. Plasma levels of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 correlate with disease stage and survival in colorectal cancer patients. Dis Colon Rectum. 2005;48:700–710
  48. Schietroma M, Carlei F, Franchi L, et al. Comparison of serum interleukin-6 concentrations in patients treated by cholecystectomy via laparotomy or laparoscopy. Hepatogastroenterology. 2004;51:1595–1599
  49. Belizon A, Balik E, Jain S, et al. PDGF is elevated in patients with colonic adenocarcinoma. (abstract) Dis Colon Rectum. 2006;49(5):723
  50. Offodile A, Kumara S, Hoffman A, et al. Peri-operative changes in plasma levels of Clusterin, an anti-inflammatory protein, in patients undergoing minimally invasive colorectal resection. 2007;Presented at The Society for Surgery of the Alimentary Tract Meeting, Washington, DC May

PII: S1043-1489(07)00051-6

doi: 10.1053/j.scrs.2007.10.006

Seminars in Colon & Rectal Surgery
Volume 18, Issue 4 , Pages 233-241 , December 2007

Article Tools

* Image Usage & Resolution